ACD Inhibitors describe a class of chemical compounds that are designed to target and inhibit the activity of enzymes or proteins associated with ACD, which stands for Adenylate Cyclase Domain. Adenylate cyclase is a crucial enzyme involved in cellular signaling processes, particularly in the production of cyclic adenosine monophosphate (cAMP). cAMP is a secondary messenger molecule that plays a central role in various cellular responses to extracellular signals, such as hormones, neurotransmitters, and other ligands. ACD inhibitors are primarily utilized in scientific research to investigate the intricate mechanisms of cellular signaling pathways and understand the regulation of cAMP production.
ACD inhibitors are typically small molecules or chemical compounds that can interact with the Adenylate Cyclase Domain, disrupting its catalytic activity. By inhibiting ACD, these compounds can modulate the production of cAMP, which in turn can have downstream effects on various cellular processes. Researchers use ACD inhibitors as valuable tools to probe and dissect the complex signaling cascades that rely on cAMP as a signaling molecule. These inhibitors allow scientists to manipulate specific steps in these pathways and study the consequences of altered cAMP levels, shedding light on the molecular mechanisms underlying various cellular responses. While ACD inhibitors may have potential applications beyond basic research, their primary purpose is to facilitate the exploration of cell signaling processes.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
An anthracycline that intercalates DNA and inhibits topoisomerase II, potentially reducing ACD transcription indirectly. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
A compound that binds to DNA, potentially inhibiting transcription factors from binding to the ACD promoter region. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog of cytidine that may incorporate into RNA and DNA, potentially disrupting DNA methylation and affecting ACD expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that could lead to hypomethylation of the ACD gene promoter and downregulate its expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that has been shown to inhibit the transcription of various genes, which could include ACD. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
A compound that intercalates into DNA, inhibiting RNA polymerase action and potentially suppressing ACD mRNA synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A compound that can intercalate in DNA, potentially affecting DNA replication and transcription, including that of ACD. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
A topoisomerase I inhibitor that can lead to DNA damage and potentially affect the transcription of various genes, like ACD. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that might alter chromatin structure and indirectly impact ACD transcription. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
A natural product that inhibits translation and could decrease ACD protein levels post-transcriptionally. | ||||||